TRICOR Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Tricor, and when can generic versions of Tricor launch?

Tricor is a drug marketed by Abbvie and is included in three NDAs.

The generic ingredient in TRICOR is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Tricor

A generic version of TRICOR was approved as fenofibrate by RHODES PHARMS on May 13^th, 2005.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TRICOR?
What are the global sales for TRICOR?
What is Average Wholesale Price for TRICOR?

Summary for TRICOR

US Patents:	0
Applicants:	1
NDAs:	3
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	138
Clinical Trials:	21
Patent Applications:	4,097
Drug Prices:	Drug price information for TRICOR
Drug Sales Revenues:	Drug sales revenues for TRICOR
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for TRICOR
What excipients (inactive ingredients) are in TRICOR?	TRICOR excipients list
DailyMed Link:	TRICOR at DailyMed

Drug patent expirations by year for TRICOR

Recent Clinical Trials for TRICOR

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Lindsay Ferguson, MD	Phase 1
Shriners Hospitals for Children	Phase 2/Phase 3
National Institute of General Medical Sciences (NIGMS)	Phase 2/Phase 3

See all TRICOR clinical trials

Pharmacology for TRICOR

Drug Class	Peroxisome Proliferator Receptor alpha Agonist

Paragraph IV (Patent) Challenges for TRICOR

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
TRICOR	Tablets	fenofibrate	48 mg	021656	1	2008-07-01
TRICOR	Tablets	fenofibrate	145 mg	021656	1	2007-10-19

US Patents and Regulatory Information for TRICOR

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021656-001	Nov 5, 2004		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	TRICOR (MICRONIZED)	fenofibrate	CAPSULE;ORAL	019304-004	Jun 30, 1999		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021203-003	Sep 4, 2001		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021203-001	Sep 4, 2001		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021656-002	Nov 5, 2004		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Abbvie	TRICOR (MICRONIZED)	fenofibrate	CAPSULE;ORAL	019304-003	Jun 30, 1999		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for TRICOR

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021203-001	Sep 4, 2001	⤷ Sign Up	⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021656-001	Nov 5, 2004	⤷ Sign Up	⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021203-003	Sep 4, 2001	⤷ Sign Up	⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021656-001	Nov 5, 2004	⤷ Sign Up	⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021203-003	Sep 4, 2001	⤷ Sign Up	⤷ Sign Up
Abbvie	TRICOR	fenofibrate	TABLET;ORAL	021203-001	Sep 4, 2001	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for TRICOR

See the table below for patents covering TRICOR around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Germany	60121570		⤷ Sign Up
Denmark	0499299		⤷ Sign Up
South Korea	20050026705	NANOPARTICULATE FIBRATE FORMULATIONS	⤷ Sign Up
New Zealand	228130	THERAPEUTIC COMPOSITION COMPRISING FENOFIBRATE AND A SOLID SURFACTANT WHICH HAS BEEN CO-MICRONISED; PREPARATORY PROCESS	⤷ Sign Up
Cyprus	2396	Pharmaceutical composition of fenofibrate with high biological availability and method for preparingsame.	⤷ Sign Up
Austria	195416		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration